Clinical updates from Asia-Pacific, including data readouts and publications: Innocare, Jyong, Kazia.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Nasus, Nxera.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Amplia Therapeutics, Immunofoco Biotechnology, Lynk Pharmaceuticals, Teva Pharmaceutical Industries.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Hutchmed, Incyte Biosciences, Kahr Medical, Nanjing Delova Biotech

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Immutep, Foresee Pharmaceuticals.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascletis, Astellas, Innocare, Innovent, Neuexcell, Radiopharm, Sol-Gel, Takeda, .

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Ascentage, Ascletis, Biomx, Deciphera, Innocare, Innovent, Kazia, Lyell, Vivacta Bio.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Eisai, Immvira, Impact, Kelun-Biotech, Mabwell, Tramscenta.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascentage, Biomx, Celltrion, Enlivex, Junshi, Kelun-Biotech, Renalys.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Jyong Biotech, Lynk, Innovent.